A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

IsraelRecruitingPHASE3

Conditions

Type 1 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Scottsdale Clinical Trials- Site Number : 8400044, Scottsdale, Arizona, United States

    Contact: Study coordinator (Lisette Partipilo) · lpartipilo@scottsdaletrials.com · 480-382-7909
  • Marvel Clinical Research- Site Number : 8400042, Huntington Beach, California, United States

  • University of California San Francisco - Mission Bay- Site Number : 8400011, San Francisco, California, United States

    Contact: Study coordinator (Rebecca Wesch) · clinicalresearch@ucsf.edu · 844-813-8273
  • Barbara Davis Center for Childhood Diabetes- Site Number : 8400031, Aurora, Colorado, United States

  • Yale University School of Medicine- Site Number : 8400005, New Haven, Connecticut, United States

  • University of Florida College of Medicine- Site Number : 8400054, Gainesville, Florida, United States

    Contact: Study coordinator (Michael Haller) · hallemj@peds.ufl.edu · 352-294-5760
    Contact: Study coordinator (Sarah Peeling) · smpeeling@peds.ufl.edu
  • Encore Medical Research - Hollywood- Site Number : 8400061, Hollywood, Florida, United States

  • University of South Florida- Site Number : 8400013, Tampa, Florida, United States

    Contact: Study coordinator (Bethany Dunn) · eadunn3@usf.edu · 813-974-4886
  • AdventHealth Winter Park- Site Number : 8400033, Winter Park, Florida, United States

  • Atlanta Diabetes Associates- Site Number : 8400036, Atlanta, Georgia, United States

    Contact: Study coordinator (Heidi Capria) · hcapria@atlantadiabetes.com · 404-357-0880
  • IACT Health - Columbus - Talbotton Road- Site Number : 8400003, Columbus, Georgia, United States

    Contact: Study coordinator (Dr. Steven Leichter) · Sleichter@centricityresearch.com · 706-996-2921
  • Institute of Endocrinology Diabetes, Health & Hormones- Site Number : 8400050, Stockbridge, Georgia, United States

    Contact: Study coordinator (Luis Molina) · luis.molina@sitebridgeresearch.com · 919-250-3320
  • St. Luke's Children's Hospital- Site Number : 8400014, Boise, Idaho, United States

    Contact: Study coordinator (Xanti Gerrard) · gerrardx@slhs.org · 208-381-9433
  • Rocky Mountain Clinical Research - Idaho Falls- Site Number : 8400001, Idaho Falls, Idaho, United States

    Contact: Study coordinator (Joshua Smith) · jms-research@idahomed.com · 208-525-3739
  • Norton Children's Research Institute - Wendy Novak Diabetes Institute- Site Number : 8400016, Louisville, Kentucky, United States

  • C.S. Mott Children's Hospital- Site Number : 8400015, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Aimee Katona) · PEDS-ENDO-DM-Research@med.umich.edu · 734-615-4079
  • Mayo Clinic in Rochester - Minnesota- Site Number : 8400019, Rochester, Minnesota, United States

    Contact: Study coordinator (Yogish Kudva) · kudva.yogish@mayo.edu · 507-284-3964
  • Children's Mercy Adelle Hall Campus- Site Number : 8400010, Kansas City, Missouri, United States

    Contact: Study coordinator (Angela Wiedner) · endoclinicaltrials@cmh.edu · 816-460-1097
  • University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006, Buffalo, New York, United States

  • Endocrine Associates of West Village- Site Number : 8400064, New York, New York, United States

    Contact: Study coordinator (Dr. Anastasios Manessis) · ymesen@endocrinenyc.com · 516-574-9232
  • Columbia University Irving Medical Center- Site Number : 8400009, New York, New York, United States

  • Asheville Clinical Research- Site Number : 8400045, Asheville, North Carolina, United States

    Contact: Study coordinator (Lauren Elizabeth Bernstein) · bbernstein@ashevilleclinicaltrials.com · 18285792273
    Contact: Study coordinator (Kaitlyn Cobb) · kcobb@ashevilleclinicaltrials.com
  • The Ohio State University- Site Number : 8400051, Columbus, Ohio, United States

    Contact: Study coordinator (Lindsey Aldrich) · lindsey.aldrich@osumc.edu · 614-814-0772
  • The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia, Pennsylvania, United States

  • AM Diabetes & Endocrinology Center- Site Number : 8400004, Bartlett, Tennessee, United States

  • Vanderbilt University Medical Center- Site Number : 8400020, Nashville, Tennessee, United States

  • Baylor College of Medicine- Site Number : 8400057, Houston, Texas, United States

  • UVA Children's Battle Building- Site Number : 8400060, Charlottesville, Virginia, United States

    Contact: Study coordinator (Christine Burt Solorzano) · car2r@uvahealth.org · 434-243-8236
  • Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle, Washington, United States

    Contact: Study coordinator (Sandra Lord) · slord@benaroyaresearch.org · 206-341-8956
  • MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma, Washington, United States

    Contact: Study coordinator (Rebekah Schaefer) · becky.schaefer@multicare.org · 253-403-0776
  • Investigational Site Number : 0320008, Mar del Plata, Buenos Aires, Argentina

  • Investigational Site Number : 0320003, San Miguel de Tucumán, Tucumán Province, Argentina

  • Investigational Site Number : 0320005, Buenos Aires, Argentina

  • Investigational Site Number : 0360001, Brisbane, Queensland, Australia

  • Investigational Site Number : 0360003, Adelaide, South Australia, Australia

  • Investigational Site Number : 0560005, Brussels, Belgium

  • Investigational Site Number : 0560009, Brussels, Belgium

  • Investigational Site Number : 0560007, Edegem, Belgium

  • Investigational Site Number : 0560002, Jette, Belgium

  • Investigational Site Number : 0560001, Leuven, Belgium

  • Investigational Site Number : 0560008, Leuven, Belgium

  • Investigational Site Number : 0560006, Liège, Belgium

  • Investigational Site Number : 0560004, Namur, Belgium

  • Hospital Universitario Walter Cantidio- Site Number : 0760009, Fortaleza, Ceará, Brazil

  • Centro de Diabetes Curitiba- Site Number : 0760006, Curitiba, Paraná, Brazil

  • Centro de Pesquisa Clínica de Marília - CPCLIM- Site Number : 0760002, Marília, São Paulo, Brazil

  • Hospital Universitario Clementino Fraga Filho- Site Number : 0760008, Rio de Janeiro, Brazil

  • Centro de Pesquisas Clínicas - São Paulo- Site Number : 0760011, São Paulo, Brazil

  • Hospital Israelita Albert Einstein- Site Number : 0760001, São Paulo, Brazil

  • Investigational Site Number : 1240002, Halifax, Nova Scotia, Canada

  • Investigational Site Number : 1560050, Pingxiang, Colorado, China

  • Investigational Site Number : 1560016, Luoyang, New Jersey, China

  • Investigational Site Number : 1560035, Beijing, China

  • Investigational Site Number : 1560003, Beijing, China

  • Investigational Site Number : 1560033, Beijing, China

  • Investigational Site Number : 1560009, Changchun, China

  • Investigational Site Number : 1560001, Changsha, China

  • Investigational Site Number : 1560055, Chengdu, China

  • Investigational Site Number : 1560042, Chengdu, China

  • Investigational Site Number : 1560007, Guangzhou, China

  • Investigational Site Number : 1560037, Guangzhou, China

  • Investigational Site Number : 1560040, Hangzhou, China

  • Investigational Site Number : 1560014, Hangzhou, China

  • Investigational Site Number : 1560012, Hangzhou, China

  • Investigational Site Number : 1560010, Harbin, China

  • Investigational Site Number : 1560026, Hohhot, China

  • Investigational Site Number : 1560059, Jinan, China

  • Investigational Site Number : 1560056, Lanzhou, China

  • Investigational Site Number : 1560018, Nanchang, China

  • Investigational Site Number : 1560043, Nanchang, China

  • Investigational Site Number : 1560005, Nanjing, China

  • Investigational Site Number : 1560034, Nanjing, China

  • Investigational Site Number : 1560054, Nanjing, China

  • Investigational Site Number : 1560031, Shanghai, China

  • Investigational Site Number : 1560032, Shanghai, China

  • Investigational Site Number : 1560013, Shenyang, China

  • Investigational Site Number : 1560045, Shenzhen, China

  • Investigational Site Number : 1560019, Tianjin, China

  • Investigational Site Number : 1560039, Wuhan, China

  • Investigational Site Number : 1560002, Wuhan, China

  • Investigational Site Number : 1560041, Wuxi, China

  • Investigational Site Number : 1560060, Yueyang, China

  • Investigational Site Number : 1560038, Zhengzhou, China

  • Investigational Site Number : 1560027, Zhenjiang, China

  • Investigational Site Number : 2030004, Prague, Czechia

  • Investigational Site Number : 2030003, Prague, Czechia

  • Investigational Site Number : 2030001, Prague, Czechia

  • Investigational Site Number : 2500010, La Tronche, France

  • Investigational Site Number : 2500002, Paris, France

  • Investigational Site Number : 2500008, Paris, France

  • Investigational Site Number : 2500009, Paris, France

  • Investigational Site Number : 2500005, Pau, France

  • Investigational Site Number : 2500007, Strasbourg, France

  • Investigational Site Number : 2760002, Augsburg, Germany

  • Investigational Site Number : 2760008, Bielefeld, Germany

  • Investigational Site Number : 2760005, Hanover, Germany

  • Investigational Site Number : 2760006, Leipzig, Germany

  • Investigational Site Number : 2760010, Munich, Germany

  • Investigational Site Number : 2760001, Ulm, Germany

  • Investigational Site Number : 3760005, Jerusalem, Israel

  • Investigational Site Number : 3760002, Petah Tikva, Israel

  • Investigational Site Number : 3760003, Petah Tikva, Israel

  • Investigational Site Number : 3760001, Ramat Gan, Israel

  • Investigational Site Number : 3760006, Rehovot, Israel

  • Investigational Site Number : 3760004, Tel Aviv, Israel

  • Azienda Ospedaliera Universitaria Meyer IRCCS - Site Number : 3800001, Florence, Firenze, Italy

    Contact: Study coordinator (Lorenzo Lenzi) · lorenzo.lenzi@meyer.it · +39 0555662934
  • IRCCS Istituto Giannina Gaslini - Site Number : 3800008, Genoa, Genova, Italy

    Contact: Study coordinator (Giordano Spacco) · +39 01056362528
  • Ospedale dei Bambini Vittore Buzzi - Site Number : 3800005, Milan, Milano, Italy

    Contact: Study coordinator (Chiara Mameli) · gianvincenzo.zuccotti@unimi.it · +39 0263635324
  • Investigational Site Number : 3800011, Milan, Milano, Italy

  • AOU Policlinico Umberto I, UOC Diabetologia -Site Number : 3800012, Rome, Roma, Italy

    Contact: Study coordinator (Raffaella Buzzetti) · diabetologia@policlinicoumberto1.it
  • Investigational Site Number : 3800003, Rome, Roma, Italy

  • Investigational Site Number : 3800010, Turin, Torino, Italy

  • Investigational Site Number : 3800014, Messina, Italy

  • AOU Maggiore della Carità - Site Number : 3800015, Novara, Italy

    Contact: Study coordinator (Ivana Rabbone) · ivana.rabbone@uniupo.it
  • Azienda Ospedaliera Universitaria Integrata di Verona -Site Number : 3800002, Verona, Italy

    Contact: Study coordinator (Claudio Maffeis) · claudio.maffeis@univr.it · +39 0458127664
  • Investigational Site Number : 3920020, Nagoya, Aichi-ken, Japan

  • Investigational Site Number : 3920007, Koshigaya, Saitama, Japan

  • Investigational Site Number : 3920017, Nara, Japan

  • Investigational Site Number : 5280003, Amersfoort, Netherlands

  • Investigational Site Number : 5280002, Leiden, Netherlands

  • Investigational Site Number : 5280001, Rotterdam, Netherlands

  • Investigational Site Number : 6160005, Lodz, Lódzkie, Poland

  • Investigational Site Number : 6160001, Warsaw, Masovian Voivodeship, Poland

  • Investigational Site Number : 6160006, Bialystok, Poland

  • Investigational Site Number : 7240012, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240017, Barcelona, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240004, Esplugues de Llobregat, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240003, Sabadell, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240020, Barakaldo, Basque Country, Spain

  • Investigational Site Number : 7240023, Alcalá de Henares, Madrid, Spain

  • Investigational Site Number : 7240016, Pamplona, Navarre, Spain

  • Investigational Site Number : 7240014, Pontevedra, Pontevedra [Pontevedra], Spain

  • Investigational Site Number : 7240019, San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain

  • Investigational Site Number : 7240021, Seville, Sevilla, Spain

  • Investigational Site Number : 7240001, Seville, Sevilla, Spain

  • Investigational Site Number : 7240006, Madrid, Spain

  • Investigational Site Number : 7240010, Madrid, Spain

  • Investigational Site Number : 7240009, Madrid, Spain

  • Investigational Site Number : 7240011, Madrid, Spain

  • Investigational Site Number : 7240007, Madrid, Spain

  • Investigational Site Number : 7240022, Málaga, Spain

  • Investigational Site Number : 7240015, Palma, Spain

  • Investigational Site Number : 8260001, Cambridge, Cambridgeshire, United Kingdom

  • Investigational Site Number : 8260004, Dundee, Dundee City, United Kingdom

  • Investigational Site Number : 8260009, London, England, United Kingdom

  • Investigational Site Number : 8260012, London, England, United Kingdom

  • Investigational Site Number : 8260002, Glasgow, Glasgow City, United Kingdom

  • Investigational Site Number : 8260007, London, London, City of, United Kingdom

  • Investigational Site Number : 8260011, Bath, Somerset, United Kingdom

  • Investigational Site Number : 8260006, Guildford, Surrey, United Kingdom

  • Investigational Site Number : 8260005, Leeds, United Kingdom

  • Investigational Site Number : 8260010, Reading, United Kingdom

  • Investigational Site Number : 8260003, Sheffield, United Kingdom